Eric Halioua

Company: PDC*line Pharma

Job title: President & Chief Executive Officer

Seminars:

Presenting Data from New Class of Antigen-Specific Cancer Active Immunotherapies Based on Off-The-Shelf Antigen Presenting Cell Line 2:00 pm

Following on from last year, we take a deep dive into PDC*line, potent and scalable therapeutic cancer vaccines based on a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells Examining how PDC*line is much more potent to prime and boost antitumour antigens, including neoantigens, and specific cytotoxic T-cells than conventional vaccines and improves the response…Read more

day: Conference Day Two